Official recall record
ADVIA® and Atellica® Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP) Assay
- Issuing authority
- Health Canada — Medical Devices
- Published
- 2024-08-21
- Country of alert
- Canada
- Alert level
- Type II
- Alert type
- recall
What the authority reported
Siemens Healthineers has confirmed the potential for biased quality control (qc) and patient results when using Atellica® CH Urinary/Cerebrospinal Fluid Protein (UCFP) lot 130414 on the Stellica® CH and Stellica® CI analyzers. Siemens' internal investigation confirmed when using lot 130414, QC may recover outside of the allowable control limits for urine chemistry and spinal fluid control levels. Recall start date: August 1, 2024
What to do
Follow the instructions in the official notice — recall remedies (refund, repair, replacement, or disposal) are defined by the issuing authority and the responsible business, and they differ per recall. Do not rely on summaries, including this one.
Verify at the source:
Health Canada — Medical Devices — official record →
Record last checked against the registry on 2026-05-31.
Record last checked against the registry on 2026-05-31.
ProductGuru Recalls republishes official safety information with attribution. We are not
the issuing authority and this page is not advice. If this product is a medical device or
medication, speak to a doctor or pharmacist. Found an error?
Report it — corrections are published.